Apologies, the link I posted was just the speakers. The full list of attendees is:
5am Ventures
Aastrom Biosciences, Inc
Abbott Laboratories
Actelion Pharma Ltd
Aerpio
Afaxys Inc.
Afferent Pharmaceuticals, Inc.
Agendia
Agenus Inc
Agile Therapeutics
Aileron Therapeutics
Akebia Therapeutics, Inc
Alios BioPharma, Inc.
Allon Therapeutics
AllTranz Inc
Ambit Biosciences
Amgen Inc.
Apogenix GmbH
APS International
Aquinox Pharmaceuticals Inc.
ARMGO Pharma Inc.
Array BioPharma Inc.
Ash Stevens, Inc.
Astellas
AstraZeneca
AVEO Oncology
Avexxin AS
Barclays Capital
Bayer HealthCare
BIND Biosciences, Inc.
BioAxone Biosciences
BioCrea
BioNTech AG
Biota Holdings Limited
BMO Capital Markets
Boehringer Ingelheim
Bristol-Myers Squibb
Brown University
Campbell Alliance
CardioVascular BioTherapeutics, Inc.
Catabasis Pharmaceuticals, Inc
Ceres Oncology
Cerulean Pharma Inc.
ChanRx Corp.
Chimerix Inc.
CoNCERT Pharmaceuticals, Inc.
Cortendo
Cowen and Company
CrystalGenomics, Inc.
Cubist Pharmaceuticals Inc.
Cynapsus Therapeutics Inc
Cytokinetics Inc.
Daiichi Sankyo
Debiopharm SA
Dicerna Pharmaceuticals
Druggability Technologies
Durata Therapeutics
Eli Lilly & Co
Elsevier Business Intelligence
EMD Serono
Endo Pharmaceuticals
EnGeneIC
EnVivo Pharmaceuticals
Esperion Therapeutics
Galenea Corp
Genentech
Genzyme
GlaxoSmithKline
Greenhill & Co.
GTx
Healogix LLC
Healthcare Ventures LLC
Helsinn Healthcare SA
Herndon & Company
Hoffman-LaRoche, Inc.
Hygeia Therapeutics Inc
Infinity Pharmaceuticals
Inotek Pharmaceuticals
IP Technology Exchange, Inc.
Ironwood Pharmaceuticals
J&J Development Corporation
Janssen Pharmaceuticals, Inc.
Jennerex Biotherapeutics
Johnson & Johnson
KaloBios Pharmaceuticals, Inc.
Karyopharm Inc.
Kyowa Hakko Kirin Co., Ltd
Lee International IP & Law Group
MacroGenics, Inc.
Medtronic
MEI Pharma, Inc.
Merck & Co., Inc.
Merck Serono
MIT
Momenta Pharmaceuticals, Inc.
MPM Capital
Naurex Inc.
Nektar Therapeutics
Neuren Pharmaceuticals
NI Research
Novartis Pharmaceuticals Corporation
Novo Nordisk A/S
Novozymes Biopharma
OvaScience, Inc.
Oxford Bioscience Partners
Partners HealthCare System Inc
Pfizer Inc
Pfizer Specialty Care BU
Pharmaceutical Regulatory Services
Polaris Venture Partners
Procter & Gamble
Pronai Therapeutics
Purdue Pharma
Ranbaxy Inc.
Reckitt Benckiser Pharmaceutic
Regeneron Pharmaceuticals, Inc
Resverlogix Corp.
Rib-X Pharmaceuticals, Inc.
Sanofi
Sarepta Therapeutics
Selecta Biosciences
Shire Human Genetic Therapies
Sofinnova Ventures
Sunovion Pharmaceuticals Inc.
SUNY Upstate Medical University
Supernus Pharmaceuticals, Inc.
Synthonics
Targacept, Inc.
the henry m jackson foundation
Theraclone Sciences, Inc.
TiGenix NV
Trellis Bioscience, LLC
Tufts Cummings School of Veterinary Medicine
University College Dublin, Ireland
University of Rochester
Vectura
ViaCyte, Inc
Virobay, Inc
Vitae Pharmaceuticals, Inc.
Vogel BioConsulting
Windhover Information Inc.
Wolpert & Associates
Woodside Capital Partners
Xcovery
Zalicus Inc.
Zymeworks Inc.
- Forums
- ASX - By Stock
- NEU
- bell potters no 1 biotech
bell potters no 1 biotech, page-117
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.13 |
Change
0.020(0.15%) |
Mkt cap ! $1.678B |
Open | High | Low | Value | Volume |
$13.20 | $13.44 | $13.07 | $5.021M | 378.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 11501 | $13.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.18 | 1539 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 11501 | 13.120 |
2 | 3525 | 13.110 |
5 | 4049 | 13.100 |
1 | 1927 | 13.080 |
2 | 264 | 13.070 |
Price($) | Vol. | No. |
---|---|---|
13.180 | 1539 | 1 |
13.210 | 1700 | 1 |
13.230 | 18 | 2 |
13.260 | 1927 | 1 |
13.280 | 1927 | 1 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
SBW
Shekel Brainweigh reports a 50% revenue increase in its Retail Innovation suite and delivers the first batch of 20 Smart Bays to Hitachi as part of a larger order
NEU (ASX) Chart |